IQGAP2 and cancer: The authors demonstrated that IQGAP2 can suppress the transcriptional activity of β-catenin, a downstream protein in Wnt signaling, which leads to an inhibition of cancer cell epithelial-mesenchymal transition, migration, and invasion.